Diabetes, obesity & metabolism
Efficacy and safety of GLP-1 receptor agonists and SGLT2 inhibitors as adjuncts to insulin in type 1 diabetes: Systematic review and meta-analysis.
Sama M Abdel-Rahman, Rama Al-Shiab, Ermeena Shah, Mustafa Güldan, Ahmet Bahadır Ak, Zeynep Y Yilmaz, Derya Göksu Fidan, Lasin Ozbek, Mehmet Kanbay
Published: 202610.1111/dom.70506
Abstract
AIMS: Adjunctive therapies to insulin for type 1 diabetes mellitus (T1DM), including glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is), may improve glycaemic control and reduce insulin requir…
Preview only. Read the full abstract at the source